Login
$CISS
$0.49 -$0.00 (0.16%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2025
As of Dec 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q4 FY2023
As of Dec 31, 2023
Assets
Current assets
Cash and cash equivalents
Time deposits
Trade and other receivables
Other current assets
Operating lease right-of-use assets
Advances and prepayments
Inventories
Total current assets
Non current assets
Vessels, net
Total non current assets
Total assets
Liabilities and Stockholders' Equity
Current liabilities
Trade accounts payable
Payable to related parties
Accrued and other liabilities
Operating lease liabilities
Deferred income
Total current liabilities
Warrant liability
Total non current liabilities
Total liabilities
Capital stock, $0.01 par value, 2,000,000,000 shares authorized at December 31, 2024 and 2025, 35,324 and 659,668 issued and outstanding at December 31, 2024 and 2025, respectively (Note 8)
Preferred Stock, 200,000,000 shares authorized (Note 8) Preferred stock, Series A, $0.01 par value, 600,000 shares issued and outstanding as of December 31, 2024 and December 31, 2025 (Note 8)
Additional paid-in capital
Retained earnings
Total stockholders' equity
Total liabilities and stockholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support